Response of neuroblastoma cells to ionizing radiation: Modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells

International Journal of Oncology

Volumn 29, Issue 6, 2006, Pages 1525-1531

  Jadhav, Unmesh ^a   Mohanam, Sanjeeva ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Angiogenesis; Endothelial cells; Invasion; Irradiation; Neuroblastoma

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; LAMININ; MATRIGEL; PROTEOGLYCAN; UROKINASE; VASCULOTROPIN A;

ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL MOTION; CYTOLOGY; DRUG COMBINATION; ENDOTHELIUM CELL; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NEUROBLASTOMA; PATHOLOGY; RADIATION EXPOSURE; TUMOR CELL LINE; VASCULARIZATION;

CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; PROTEOGLYCANS; TRANSCRIPTION, GENETIC; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35148882525     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.6.1525     Document Type: Article

References (49)

1. Maris JM and Matthay KK: Molecular biology of neuroblastoma. J Clin Oncol 17: 2264-2279, 1999.
2. Escobar MA, Grosfeld JL, Powell RL, West KW, Scherer LR III, Fallon RJ and Rescorla FJ: Long-term outcomes in patients with stage IV neuroblastoma. J Pediatr Surg 41: 377-381, 2006. (Pubitemid 43233858)
3. Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM and Matthay KK: Biologic factors determine prognosis in infants with stage IV neuroblastoma: a prospective Children's Cancer Group study. J Clin Oncol 18: 1260-1268, 2000. (Pubitemid 30159844)
4. Laprie A, Michon J, Hartmann O, Munzer C, Leclair MD, Coze C, Valteau-Couanet D, Plantaz D, Carrie C, Habrand JL, Bergeron C, Chastagner P, Defachelles AS, Delattre O, Combaret V, Benard J, Perel Y, Gandemer V and Rubie H: Neuroblastoma Study Group of the French Society of Pediatric Oncology. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system stage II and III neuroblastoma with MYCN amplification. Cancer 101: 1081-1089, 2004.
5. Escobar MA, Grosfeld JL, Powell RL, West KW, Scherer LR III, Fallon RJ and Rescorla FJ: Long-term outcomes in patients with stage IV neuroblastoma. J Pediatr Surg 41: 377-381, 2006. (Pubitemid 43233858)
6. Von Allmen D, Grupp S, Diller L, Marcus K, Ecklund K, Meyer J and Shamberger RC: Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg 40: 936-941, 2005. (Pubitemid 40840808)
7. Jadhav U, Chigurupati S, Lakka SS and Mohanam S: Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 25: 1407-1414, 2004.
8. Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero WC and Rao JS: Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Oncogene 21: 7824-7830, 2002. (Pubitemid 35398840)
9. Chandrasekar N, Mohanam S, Gujrati M, Olivero WC, Dinh DH and Rao JS: Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene 22: 392-400, 2003.
10. Yanamandra N, Gumidyala KV, Waldron KG, Gujrati M, Olivero WC, Dinh DH, Rao JS and Mohanam S: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene 23: 2224-2230, 2004. (Pubitemid 38482537)
11. O'Reilly R, Cheung NK, Bowman L, Castle V, Hoffer F, Kapoor N, Kletzel M, Lindsley K, Shamberger R and Tubergen D: NCCN pediatric neuroblastoma practice guidelines. The National Comprehensive Cancer Network. Oncology 10: 1813-1822, 1996.
12. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB and Reynolds CP: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341: 1165-1173, 1999.
13. Kushner BH, Wolden S, La Quaglia MP, Kramer K, Verbel D, Heller G and Cheung NK: Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol 19: 2821-2828, 2001. (Pubitemid 32538190)
14. Bradfield SM, Douglas JG, Hawkins DS, Sanders JE and Park JR: Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma. Cancer 100: 1268-1275, 2004.
15. Komuro H, Kaneko S, Kaneko M and Nakanishi Y: Expression of angiogenic factors and tumor progression in human neuroblastoma. J Cancer Res Clin Oncol 127: 739-743, 2001. (Pubitemid 33079374)
16. Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM and Himelstein BP: High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 6: 1900-1908, 2000.
17. Marcus K, Johnson M, Adam RM, O'Reilly MS, Donovan M, Atala A, Freeman MR and Soker S: Tumor cell-associated neuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma. Neuropathology 25: 178-187, 2005.
18. Fukata S, Inoue K, Kamada M, Kawada C, Furihata M, Ohtsuki Y and Shuin T: Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma. Cancer 103: 931-942, 2005.
19. Hovinga KE, Stalpers LJ, van Bree C, Donker M, Verhoeff JJ, Rodermond HM, Bosch DA and van Furth WR: Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines - a clue to radioresistance? J Neurooncol 74: 99-103, 2005.
20. Brieger J, Schroeder P, Gosepath J and Mann WJ: Vascular endothelial growth factor and basic fibroblast growth factor are released by squamous cell carcinoma cells after irradiation and increase resistance to subsequent irradiation. Int J Mol Med 16: 159-164, 2005.
21. Chung YL, Jian JJ, Cheng SH, Tsai SY, Chuang VP, Soong T, Lin YM and Horng CF: Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma. Clin Cancer Res 12: 2706-2715, 2006.
22. Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H and Hallahan DE: Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 61: 2413-2419, 2001.
23. Dano K, Romer J, Nielsen BS, Bjorn S, Pyke C, Rygaard J and Lund LR: Cancer invasion and tissue remodeling - cooperation of protease systems and cell types. APMIS 107: 120-127, 1999.
24. Adair JC, Baldwin N, Kornfeld M and Rosenberg GA: Radiation-induced blood-brain barrier damage in astrocytoma: relation to elevated gelatinase B and urokinase. J Neurooncol 44: 283-289, 1999.
25. Yamashita K, Tanaka Y, Mimori K, Inoue H and Mori M: Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma. Int J Cancer 110: 201-207, 2004.
26. Li P, Gao Y, Ji Z, Zhang X, Xu Q, Li G, Guo Z, Zheng B and Guo X: Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma. J Pediatr Surg 39: 1512-1519, 2004. (Pubitemid 39349734)
27. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997. (Pubitemid 27371946)
28. Ribatti D, Surico G, Vacca A, De Leonardis F, Lastilla G, Montaldo PG, Rigillo N and Ponzoni M: Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma. Life Sci 68: 1161-1168, 2001. (Pubitemid 32168042)
29. Sugiura Y, Shimada H, Seeger RC, Laug WE and De Clerck YA: Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res 58: 2209-2216, 1998. (Pubitemid 28232910)
30. Yu Q and Stamenkovic I: Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13: 35-48,1999. (Pubitemid 29045114)
31. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002. (Pubitemid 37328786)
32. Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussens LM and De Clerck YA: Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res 64: 1675-1686, 2004.
33. Ribatti D, Alessandri G, Vacca A, Iurlaro M and Ponzoni M: Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo. Int J Cancer 77: 449-454, 1998. (Pubitemid 28299883)
34. Farina AR, Tacconelli A, Vacca A, Maroder M, Gulino A and Mackay AR: Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. Cell Growth Differ 10: 353-367, 1999.
35. Bjornland K, Bratland A, Rugnes E, Pettersen S, Johansen HT, Aasen AO, Fodstad O, Ree AH and Maelandsmo GM: Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells. J Pediatr Surg 36: 1040-1044, 2001.
36. Sartor L, Negro A, Barletta E, Mugnai G and Garbisa S: Modulation of proteolytic potential and differentiation by CNTF and BDNF in two mouse neuroblastoma clones: relation to invasion. Clin Exp Metastasis 19: 709-716, 2002. (Pubitemid 36092267)
37. Wild-Bode C, Weller M, Rimner A, Dichgans J and Wick W: Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744-2750, 2001. (Pubitemid 32685864)
38. Wick W, Wick A, Schulz JB, Dichgans J, Rodemann HP and Weller M: Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase. Cancer Res 62: 1915-1919, 2002.
39. Qian LW, Mizumoto K, Urashima T, Nagai E, Maehara N, Sato N, Nakajima M and Tanaka M: Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 8: 1223-1227, 2002.
40. Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J and Deutsch E: Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Mol Cancer Ther 4: 1717-1728, 2005.
41. Schweigerer L, Rave-Frank M, Schmidberger H and Hecht M: Sublethal irradiation promotes invasiveness of neuroblastoma cells. Biochem Biophys Res Commun 330: 982-988, 2005.
42. Rofstad EK, Mathiesen B and Galappathi K: Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 64: 13-18, 2004.
43. Wei LH, Lai KP, Chen CA, Cheng CH, Huang YJ, Chou CH, Kuo ML and Hsieh CY: Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through down-regulation of nuclear factor kappaB. Oncogene 24: 390-398, 2005.
44. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J and O'Reilly MS: Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61: 2207-2211, 2001.
45. Iwakawa M, Kaneko M and Ikebulkuro K: Enhanced metastasis after local therapy in a murine model using C-1300 neuroblastoma. J Pediatr Surg 34: 1645-1646, 1999.
46. Zhai GG, Malhotra R, Delaney M, Latham D, Nestler U, Zhang M, Mukherjee N, Song Q, Robe P and Chakravarti A: Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. J Neurooncol 76: 227-237, 2006.
47. Brown CK, Khodarev NN, Yu J, Moo-Young T, Labay E, Darga TE, Posner MC, Weichselbaum RR and Mauceri HJ: Glioblastoma cells block radiation-induced programmed cell death of endothelial cells. FEBS Lett 565: 167-170, 2004.
48. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW and Weichselbaum RR: Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59: 3374-3378, 1999.
49. Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G and Giavazzi R: Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63: 5224-5229, 2003.